Non-association between polymorphisms of the frizzled receptor genes and bone mineral density in postmenopausal Korean women

J Korean Med Sci. 2009 Jun;24(3):443-7. doi: 10.3346/jkms.2009.24.3.443. Epub 2009 Jun 12.

Abstract

We investigated the association between single nucleotide polymorphisms (SNPs) in the frizzled (FZD) genes in the Wnt signal pathway and circulating osteoprotegerin (OPG), soluble receptor activator of NF-kappaB ligand (sRANKL) levels, bone turnover markers, and bone mineral density (BMD) in postmenopausal women. The SNPs in the FZD1, FZD5, FZD6, FZD7, and FZD9 genes were analyzed by direct sequencing in 371 postmenopausal Korean women. Levels of serum OPG, sRANKL, osteocalcin, C-telopeptide of type I collagen, calcium, parathyroid hormone and calcitonin, and BMD at the lumbar spine and femoral neck were measured. The SNPs in the FZD1, FZD5, FZD7, and FZD9 genes, and in exon 2 of the FZD6 gene were not observed. No significant differences in the adjusted BMD of lumbar spine and femoral neck and serum levels of OPG, sRANKL, and bone markers were noted among the single or haplotype genotypes of the L345M and E664A SNPs in the FZD6 gene and the distributions of these single or haplotype genotypes were not different according to the bone mass status. In conclusion, the polymorphisms of the FZD genes are not associated with BMD of the lumbar spine and femoral neck, bone turnover markers, or circulating OPG-sRANKL in Korean women.

Keywords: Biological Markers; Bone Density; Frizzled Receptors; Osteoprotegerin; Polymorphism, Genetic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Asian People / genetics*
  • Biomarkers / analysis
  • Bone Density / genetics*
  • Female
  • Frizzled Receptors / genetics*
  • Gene Frequency
  • Genotype
  • Humans
  • Middle Aged
  • Osteoprotegerin / metabolism
  • Polymorphism, Single Nucleotide*
  • Postmenopause
  • Receptor Activator of Nuclear Factor-kappa B / metabolism

Substances

  • Biomarkers
  • Frizzled Receptors
  • Osteoprotegerin
  • Receptor Activator of Nuclear Factor-kappa B